Key result
Contemporary kidney failure risk prediction tools are widely validated for moderate CKD but may overestimate risk in older patients with advanced CKD due to the competing risk of death.
Why the study?
Clinicians have an ever-increasing number of prediction tools for estimating kidney failure risk, warranting a review of contemporary evidence and interpretation across the CKD spectrum.
Risk prediction models for kidney failure must account for the competing risk of death in older patients with advanced CKD to prevent risk overestimation.
Current tools may overestimate kidney failure risk in older advanced CKD; leaves open need for competing-risk adjusted models in validation studies.
PURPOSE OF REVIEW: Clinicians have an ever-increasing number of prediction tools at their disposal for estimating the risk of kidney failure in their patients. This review aims to summarize contemporary evidence for chronic kidney disease (CKD) risk prediction models across the spectrum of kidney function, and explore nuances in the interpretation of risk estimates. RECENT FINDINGS: A European study using predominantly laboratory data has extended kidney failure prediction to patients with more preserved estimated glomerular filtration rate. For older patients with advanced CKD, prediction tools that censor for death (such as the Kidney Failure Risk Equation) overestimate the risk of kidney failure, especially over time horizons longer than 2 years. This problem can be addressed by accounting for the competing risk of death, as shown in well designed validation studies. The clinical utility of kidney failure risk prediction tools is being increasingly tested at a population level to inform policy and referral guidelines. SUMMARY: There is welcome trend to validate existing prediction tools in diverse clinical settings and identify their role in clinical practice. Clinicians should be cognizant of overestimating kidney failure risk in older patients with advanced CKD due to the competing risk of death. For moderate CKD and for short-term predictions, the Kidney Failure Risk Equation remains the most widely validated prediction tool.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a review in Chronic kidney disease (CKD). Kidney failure risk prediction models was evaluated. Contemporary kidney failure risk prediction tools are widely validated for moderate CKD but may overestimate risk in older patients with advanced CKD due to the competing risk of death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: